Joint HMA/EMA workshop on artificial intelligence in medicines regulation

Table of contents

Date: 19/04/2021 to 20/04/2021
Location: Virtual event

Event summary

Artificial intelligence (AI) and novel digital technologies hold the promise of increasing efficiency and capacity in healthcare and of providing deeper insights from big data. The HMA-EMA Joint Big Data Task Force recommended to strengthen the network ability in AI, which is reflected in the Big Data Steering Group work plan.

The objective of this workshop is to:

  • Inform on state-of-the art use of AI in medicines with keynote presentations;
  • Hear the views of stakeholders and experts on the AI actions in the Big Data Taskforce and identify any gaps.

For more information, see Big data.

Documents

Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to the European Medicines Agency instead.

Order